Institution Partners | CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and clinical trial access.

I am typing this as I wait to be called back for scans. The miracle of imaging and the advances that have been made in the 17 years since my diagnosis do not escape me. I will soon receive the results ...

He thought CAR-T therapy marked the end of cancer. Months later, another diagnosis revealed the power of faith, hope and resilience.

Irene Flores' advocacy for bedside nurses helped build a local stem cell transplant program, making her an Extraordinary Healer Award nominee.

Local transplant availability reduced patient travel burden and preserved continuity for long-term oncology relationships, reinforcing the program’s mission around access and community-based care.

Three new studies from WCLC 2026 show strong results in ROS1-positive NSCLC, EGFR-mutant NSCLC and relapsed small cell lung ...

Patients in CONVERGE have stage 3 lung cancer and receive chemotherapy and radiation at the same time, followed by the immunotherapy Imfinzi (durvalumab) given by IV. Even with that treatment, fully ...

Venesection, the term used in the United Kingdom for therapeutic phlebotomy, has long been a standard treatment for PV. The procedure removes blood to help keep red blood cell levels under control, ...

September is Blood Cancer Awareness Month, and the pipeline for leukemia, lymphoma and myeloma is as active as it has been in years. One CAR T-cell therapy for multiple myeloma is awaiting an FDA ...

FDA approves Inluriyo plus Verzenio for adults with ESR1-mutated, ER-positive, HER2-negative advanced or metastatic breast ...

Follow Jennifer Tipton’s simple exercises to keep your body moving.

Children with diffuse midline glioma who took Keppra lived a median of 20.96 months, compared with 9.92 months for those who did not, a new study found.